One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Expanded CD8+CD38+ T Cell Population in Patients With Systemic Lupus Erythematosus Is Linked to Increased Infection Rates: A Prospective Study
doi : 10.1002/acr2.11725
SOX-5 Transcription Factor: a Novel Psoriatic Autoantigen Preferentially Found in Women
doi : 10.1002/acr2.11740
Prevalence and Risk of Immunostimulatory Herbal Supplement Treatment Among Autoimmune Dermatology Patients
doi : 10.1002/acr2.11735
Substituting Medical Cannabis for Medications Among Patients with Rheumatic Conditions in the United States and Canada
doi : 10.1002/acr2.11717
Clinical Course of Interstitial Lung Disease in Patients With Rheumatoid Arthritis
doi : 10.1002/acr2.11736
Training of Peer Coaches to Assist Individuals with Knee Osteoarthritis Prepare and Recover From Total Knee Replacement
doi : 10.1002/acr2.11734
Association of Combined Autoreactivity to Sm/RNP Common Motif and U1 RNP With Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
doi : 10.1002/acr2.11739
Correction to “Clinical Image: Scleral melt in granulomatosis with polyangiitis�
doi : 10.1002/acr2.11747
Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model
doi : 10.1002/acr2.11748
Evaluation of Progression From Preclinical to Systemic Autoimmune Rheumatic Disease: Novel Use of the European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria as an Outcome Measure
doi : 10.1002/acr2.11723
Clinical Image: Brachial arteritis on positron emission tomography/computed tomography in acute eosinophilic granulomatosis with polyangiitis
doi : 10.1002/acr2.11741
Persistent Patient-Level Effect of Guselkumab at Consecutive 8-Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis: Post Hoc Analysis of a 2-Year, Phase 3, Randomized, Controlled Study
doi : 10.1002/acr2.11732
A Novel Preclinical Murine Model of Systemic Lupus Erythematosus–Like Cardiovascular Disease
doi : 10.1002/acr2.11744
Therapeutic JAK1 Inhibition Reverses Lupus Nephritis in a Mouse Model and Demonstrates Transcriptional Changes Consistent With Human Disease
doi : 10.1002/acr2.11745
The Relationship Between Anti–Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti-Sp4 Autoantibodies, and Cancer in Anti–Transcription Intermediary Factor 1γ–Positive Dermatomyositis
doi : 10.1002/acr2.11750
The Burden of Glucocorticoids: Patterns of Use, Adverse Health Conditions, and Health Care Use in Two Cohorts With Systemic Lupus Erythematosus
doi : 10.1002/acr2.11733
Single-Cell Transcriptomics Reveals a Pivotal Role of DOCK2 in Sjögren Disease
doi : 10.1002/acr2.11738
